AXSM Axsome Therapeutics Inc

USD 75.19 0.00 0
Icon

Axsome Therapeutics Inc (AXSM) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Hold

Average User
Rating

USD 75.19

0.00 (0.00)%

USD 3.57B

0.38M

USD 129.24(+71.88%)

USD 44.00 (-41.48%)

Icon

AXSM

Axsome Therapeutics Inc (USD)
COMMON STOCK | NSD
USD 75.19
0.00 0
Take a Tour
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Hold

Average User
Rating

USD 3.57B

USD 44.00 (-41.48%)

USD 75.19

Axsome Therapeutics Inc (AXSM) Stock Forecast

Show ratings and price targets of :
USD 129.24
(+71.88%)

Based on the Axsome Therapeutics Inc stock forecast from 10 analysts, the average analyst target price for Axsome Therapeutics Inc is USD 129.24 over the next 12 months. Axsome Therapeutics Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Axsome Therapeutics Inc is Slightly Bearish, which is based on 3 positive signals and 6 negative signals. At the last closing, Axsome Therapeutics Inc’s stock price was USD 75.19. Axsome Therapeutics Inc’s stock price has changed by -1.76% over the past week, +5.13% over the past month and +7.72% over the last year.

No recent analyst target price found for Axsome Therapeutics Inc
No recent average analyst rating found for Axsome Therapeutics Inc

Company Overview Axsome Therapeutics Inc

Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's commercial product portfolio includes Auvelity (dextromethorphan-bupropion), a N-methyl-D-aspartate...Read More

https://www.axsome.com

22 Cortlandt Street, New York, NY, United States, 10007

569

December

USD

USA

Adjusted Closing Price for Axsome Therapeutics Inc (AXSM)

Loading...

Unadjusted Closing Price for Axsome Therapeutics Inc (AXSM)

Loading...

Share Trading Volume for Axsome Therapeutics Inc Shares

Loading...

Compare Performance of Axsome Therapeutics Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for AXSM

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Axsome Therapeutics Inc (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc 0.00 (0.00%) USD109.10B 27.47 20.00

ETFs Containing AXSM

Symbol Name AXSM's Weight Expense Ratio Price(Change) Market Cap
SBIO
ALPS Medical Breakthrough.. 2.41 % 0.50 % 0.00 (0.00%) USD0.11B

Frequently Asked Questions About Axsome Therapeutics Inc (AXSM) Stock

Based on ratings from 10 analysts Axsome Therapeutics Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 21 buy, sell and hold ratings.

Unfortunately we do not have enough data on AXSM's stock to indicate if its a good dividend stock.

Based on targets from 10 analysts, the average taret price for AXSM is USD 129.24 over the next 12 months. The maximum analyst target price is USD 190 while the minimum anlayst target price is USD 106.

Unfortunately we do not have enough data on AXSM's stock to indicate if its overvalued.

The last closing price of AXSM's stock was USD 75.19.

The most recent market capitalization for AXSM is USD 3.57B.

Based on targets from 10 analysts, the average taret price for AXSM is projected at USD 129.24 over the next 12 months. This means that AXSM's stock price may go up by +71.88% over the next 12 months.

Following are ETFs with the highest allocation to Axsome Therapeutics Inc's stock :

SBIO

As per our most recent records Axsome Therapeutics Inc has 569 Employees.

Axsome Therapeutics Inc's registered address is 22 Cortlandt Street, New York, NY, United States, 10007. You can get more information about it from Axsome Therapeutics Inc's website at https://www.axsome.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...